Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Ann Neurol. 2016 Feb 19;79(4):535–547. doi: 10.1002/ana.24599

TABLE 3.

Number of Subjects Needed in Each Groupa to Detect a Stabilization of Disease Progression b With 80% Power

VL FF 6MWT
All ImagingDMD subjects 13 68
5.0–6.9 years 44 783
7.0–8.9 years 9 83
9.0–10.9 years 5 27
11.0–12.9 years 17 44
a

Treated and untreated.

b

No change over 1 year in treated group; change in untreated group based on the data presented in Table 2. 6MWT=6-minute walk test; DMD=Duchenne muscular dystrophy; FF=fat fraction; VL=vastus lateralis.